Cocrystal Pharma (COCP) analyst forecast and price target
Analyst forecast
Consensus of 1 analyst rating
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $6.00 from $7.00 | Jun 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 | Jan 22, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $7.00 from $10.00 | Aug 22, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | May 14, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Apr 4, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 | Mar 20, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $10.00 from $12.00 | Jan 3, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Dec 4, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Oct 4, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 15, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Aug 11, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 | Jun 2, 2023 |
| HC Wainwright & Co. | Maintained | Buy | $12.00 from $35.00 | May 24, 2023 |
Frequently asked questions
Is COCP a buy, sell, or hold?
Analysts covering Cocrystal Pharma currently average a Buy rating: 1 buy, 0 hold and 0 sell, from 1 analyst. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on COCP?
On Jun 20, 2025, HC Wainwright & Co. maintained Cocrystal Pharma at Buy with a price target of $6.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.